Videos and Podcasts on Regulatory Science at CDER
Learn how CDER is advancing regulatory science to protect public health.
- CDER Researchers – In Their Own Words
- Dr. Janet Woodcock – Advancing Regulatory Science for Public Health
Dr. Kathryn Aikin from CDER’s Office of Prescription Drug Promotion discusses how social scientists ensure that communications about prescription drugs are truthful, balanced, and accurate.
Dr. Celia Cruz explains how CDER’s Division of Product Quality Research works to enable innovation by focusing on increasing product quality and ensuring drug products are more widely available to the American public
Dr. Raj Madabushi discusses how CDER’s Office of Clinical Pharmacology applies different approaches, including mathematical modeling of drug data, to improve the drug development process.
Dr. Ashutosh Rao explains how CDER’s Office of Biotechnology Products’ research can help patients answer questions like “I left my medication on the kitchen counter for 6 hours, should I still take it?”
Dr. Lynne Yao discusses the need to develop safe and effective drugs for children, pregnant and lactating women, which CDER’s Office of New Drugs’ Division of Pediatric and Maternal Health works to address.